Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing ManagementThe Neurologist 8:227-236, Frohman,E.,et al, 2002
Hereditary Hemorrhagic TelangiectasiaNEJM 333:918-924, Guttmacher,A.E.,et al, 1995